Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Gastroenterol ; 47(5): 519-30, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22200942

RESUMO

BACKGROUND: Neutrophil gelatinase-associated lipocalin (NGAL) is a multi-potent 25-kDa protein mainly secreted by neutrophils. In inflammatory bowel disease (IBD), overexpression of NGAL in colon epithelium has been previously shown. This is the first study analyzing serum and urinary NGAL levels in IBD patients, with regard to specific characteristics of patients and disease. METHODS: Serum and urinary NGAL levels were determined in 181 patients with IBD, 93 with ulcerative colitis (UC), and 88 with Crohn's disease (CD), 82 healthy controls (HC), and 41 patients with irritable bowel syndrome (IBS). RESULTS: Serum NGAL levels were elevated in IBD patients (88.19 ± 40.75 ng/mL) compared with either HC (60.06 ± 24.18 ng/mL) or IBS patients (60.80 ± 20.30 ng/mL), P < 0.0001. No significant difference was shown between UC (86.62 ± 35.40 ng/mL) and CD (89.92 ± 46.05 ng/mL). Significantly higher levels of serum NGAL were observed in patients with active (120.1 ± 38.46) versus inactive IBD (61.58 ± 15.98), P < 0.0001. Serum NGAL displayed a strong ability to distinguish active IBD from inactive disease, healthy controls, or IBS patients with a sensitivity of 100, 95, and 95% and a specificity of 68, 83, and 79%, respectively, performing better than erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in the assessment of disease activity in both UC and CD. Urinary NGAL levels showed neither significant difference among patients and controls nor correlation with disease activity. CONCLUSIONS: Serum NGAL is elevated particularly in active IBD and correlates with established markers of inflammation and disease activity, implicating its role in the pathophysiology of IBD.


Assuntos
Proteínas de Fase Aguda/fisiologia , Doenças Inflamatórias Intestinais/fisiopatologia , Lipocalinas/fisiologia , Proteínas Proto-Oncogênicas/fisiologia , Proteínas de Fase Aguda/urina , Adolescente , Adulto , Idoso , Biomarcadores/sangue , Biomarcadores/urina , Proteína C-Reativa/metabolismo , Estudos de Casos e Controles , Colite Ulcerativa/diagnóstico , Colite Ulcerativa/metabolismo , Colite Ulcerativa/fisiopatologia , Doença de Crohn/diagnóstico , Doença de Crohn/metabolismo , Doença de Crohn/fisiopatologia , Diagnóstico Diferencial , Feminino , Humanos , Doenças Inflamatórias Intestinais/diagnóstico , Doenças Inflamatórias Intestinais/metabolismo , Síndrome do Intestino Irritável/diagnóstico , Síndrome do Intestino Irritável/metabolismo , Síndrome do Intestino Irritável/fisiopatologia , Lipocalina-2 , Lipocalinas/sangue , Lipocalinas/urina , Masculino , Pessoa de Meia-Idade , Proteínas Proto-Oncogênicas/sangue , Proteínas Proto-Oncogênicas/urina , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Adulto Jovem
2.
Eur J Echocardiogr ; 4(1): 73-5, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12565067

RESUMO

The case of a 72-year old patient with acute heart failure due to thrombosis of the mechanical mitral prosthesis is presented. The diagnosis was made by transthoracic echocardiography. The patient refused reoperation, and systemic thrombolysis was administered. After thrombolytic infusion we observe the disappearance of the echocardiographic signs of thrombosis, with concomitant improvement of symptoms.


Assuntos
Fibrinolíticos/uso terapêutico , Próteses Valvulares Cardíacas , Valva Mitral/diagnóstico por imagem , Terapia Trombolítica , Trombose/diagnóstico por imagem , Ativador de Plasminogênio Tecidual/uso terapêutico , Doença Aguda , Idoso , Ecocardiografia/métodos , Evolução Fatal , Humanos , Masculino , Falha de Prótese , Trombose/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA